Transcription factor decoys - A new model for disease intervention

被引:37
作者
Mann, MJ [1 ]
机构
[1] Univ Calif San Francisco, Div Cardiothorac Surg, San Francisco, CA 94143 USA
来源
THERAPEUTIC OLIGONUCLEOTIDES: TRANSCRIPTIONAL AND TRANSLATIONAL STRATEGIES FOR SILENCING GENE EXPRESSION | 2005年 / 1058卷
关键词
transcription factors; molecular therapy; gene therapy; gene expression;
D O I
10.1196/annals.1359.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transcription factor proteins regulate gene expression via binding to specific DNA sequences found in the promoter/enhancer regions of the genes they control. Although most transcription factor binding has been associated with an increase in gene expression, gene suppression has also been described. Transcription factor decoys are molecules that mimic the binding sites for transcription factor proteins, and compete with promoter regions to absorb this binding activity in the cell nucleus. By blocking transcription factor-chromosomal DNA interaction, these molecules provide a powerful means to manipulate the regulation of gene expression, particularly as transcription factors are increasingly understood to alter gene activation during the course of normal and pathologic processes in cell biology. As methods for cellular and nuclear delivery of these agents improve, the increasing use of transcription factor decoys, both as investigative and therapeutic tools, promises to have a significant impact on our understanding of and ability to treat human disease.
引用
收藏
页码:128 / 139
页数:12
相关论文
共 49 条
[1]   Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia [J].
Ahn, JD ;
Morishita, R ;
Kaneda, Y ;
Kim, HS ;
Chang, YC ;
Lee, KU ;
Park, JY ;
Lee, HW ;
Kim, YH ;
Lee, IK .
GENE THERAPY, 2002, 9 (24) :1682-1692
[2]   Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo [J].
Ahn, JD ;
Morishita, R ;
Kaneda, Y ;
Kim, HJ ;
Kim, YD ;
Lee, HJ ;
Lee, KU ;
Park, JY ;
Kim, YH ;
Park, KK ;
Chang, YC ;
Yoon, KH ;
Kwon, HS ;
Park, KG ;
Lee, IK .
GENE THERAPY, 2004, 11 (11) :916-923
[3]   Apoptosis, growth arrest and suppression of invasiveness by CRE-decoy oligonucleotide in ovarian cancer cells:: Protein kinase A downregulation and cytoplasmic export of CRE-binding proteins [J].
Alper, Ö ;
Bergmann-Leitner, ES ;
Abrams, S ;
Cho-Chung, YS .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2001, 218 (1-2) :55-63
[4]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[5]   Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-κB oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig [J].
Bonham, CA ;
Peng, LS ;
Liang, XY ;
Chen, ZY ;
Wang, LF ;
Ma, LL ;
Hackstein, H ;
Robbins, PD ;
Thomson, AW ;
Fung, JJ ;
Qian, SG ;
Lu, L .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :3382-3391
[6]   Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites [J].
Borgatti, M ;
Lampronti, I ;
Romanelli, A ;
Pedone, C ;
Saviano, M ;
Bianchi, N ;
Mischiati, C ;
Gambari, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) :7500-7509
[7]   Decoy oligodeoxynucleotide against activator protein-1 reduces neointimal proliferation after coronary angioplasty in hypercholesterolemic minipigs [J].
Buchwald, AB ;
Wagner, AH ;
Webel, C ;
Hecker, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (04) :732-738
[8]   Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis [J].
Chan, KS ;
Sano, S ;
Kiguchi, K ;
Anders, J ;
Komazawa, N ;
Takeda, J ;
DiGiovanni, J .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (05) :720-728
[9]  
Cho-Chung YS, 1999, CURR OPIN MOL THER, V1, P386
[10]   CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growth [J].
Cho-Chung, YS .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1998, 8 (02) :167-170